Published in Vasc Health Risk Manag on August 06, 2009
Lower extremity venous thrombosis in patients younger than 50 years of age. Vasc Health Risk Manag (2012) 0.86
Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism. Vasc Health Risk Manag (2011) 0.76
Influence of acquired and genetic risk factors on the prevention, management, and treatment of thromboembolic disease. Int J Vasc Med (2014) 0.75
High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident. Pak J Med Sci (2015) 0.75
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
World distribution of factor V Leiden. Lancet (1995) 6.22
Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA (2005) 6.16
Prevention of venous thromboembolism. Chest (2001) 5.59
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet (1994) 5.45
Venous thrombosis: a multicausal disease. Lancet (1999) 5.41
Genetic susceptibility to venous thrombosis. N Engl J Med (2001) 5.21
Risk factors for venous thromboembolism. Circulation (2003) 4.64
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med (2002) 4.18
Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young. Br J Haematol (2001) 4.04
Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) (1999) 2.85
Natural history of pulmonary embolism. Prog Cardiovasc Dis (1975) 2.83
Inherited thrombophilia: Part 1. Thromb Haemost (1996) 2.00
Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost (2002) 1.62
Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost (2008) 1.57
Congenital hypoplasia of the inferior vena cava and inherited thrombophilia: rare associated risk factors for idiopathic deep vein thrombosis. A case report. J Cardiovasc Med (Hagerstown) (2008) 1.57
Risk factors for venous thrombotic disease. Thromb Haemost (1999) 1.48
Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. Arterioscler Thromb Vasc Biol (2002) 1.48
A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood (1997) 1.42
Inherited thrombophilia: Part 2. Thromb Haemost (1996) 1.34
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost (2005) 1.27
Long-haul air travel before major surgery: a prescription for thromboembolism? Mayo Clin Proc (2005) 1.22
Deep venous thrombosis caused by congenital absence of inferior vena cava, combined with hyperhomocysteinemia. Ann Vasc Surg (2004) 1.11
Recurrent deep venous thrombosis caused by congenital interruption of the inferior vena cava and heterozygous factor V Leiden mutation. J Intern Med (2002) 1.09
[Inferior vena cava malformations and deep venous thrombosis]. Rev Esp Cardiol (2006) 1.07
The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol (2000) 1.04
Dosing and monitoring of low-molecular-weight heparins in special populations. Pharmacotherapy (2001) 1.03
Epidemiology of venous thromboembolism. Semin Vasc Med (2001) 0.98
A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis (2005) 0.97
Agenesis of the inferior vena cava associated with lower extremities and pelvic venous thrombosis. J Vasc Surg (2006) 0.94
Congenital absence of the inferior vena cava and genetic coagulation abnormalities: a rare associated risk factor for recurrent idiopathic deep vein thrombosis. Clin Appl Thromb Hemost (2003) 0.91
Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population. Br J Haematol (2000) 0.90
High prevalence of MTHFR gene A1298C polymorphism in Lebanon. Genet Test (2008) 0.87
Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications. Semin Vasc Med (2003) 0.87
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol (2002) 0.86
Cancer and thromboembolic disease: how important is the risk of thrombosis? Cancer Treat Rev (2002) 0.85
Thrombophilia as a predictor of persistent residual vein thrombosis. Haematologica (2008) 0.85
Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology (2004) 0.83
Venous thromboembolism, oral contraceptives and high prothrombin levels. J Thromb Haemost (2003) 0.83
Management of pregnant women with thrombophilia or a history of venous thromboembolism. Hematology Am Soc Hematol Educ Program (2007) 0.80
Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians. Blood Coagul Fibrinolysis (2007) 0.80
Traveller's venous thromboembolism. Cardiovasc Surg (2001) 0.80
[Agenesis of inferior vena cava combined with multiple genetic predisposition in the case of deep venous thrombosis in a young male]. Orv Hetil (2003) 0.79
Prevalence of the prothrombin G20210A polymorphism in the Lebanese population: use of a reverse hybridization strip assay approach. Mol Biol Rep (2007) 0.79
Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Int Angiol (2002) 0.79
[Thrombosis of the inferior vena cava and the iliac and femoral veins in a 24-year old man]. Dtsch Med Wochenschr (2007) 0.79
Coexistence of left-sided inferior vena cava, deep vein thrombosis of the upper and lower extremities and prothrombotic polymorphisms in a young patient: a case report. Blood Coagul Fibrinolysis (2008) 0.79
Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. Am J Hematol (2006) 0.79
Thrombophilia and pregnancy complications. Hamostaseologie (2006) 0.78
Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease annotation. Br J Haematol (2000) 0.78
Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis. Turk J Pediatr (2000) 0.77
Congenital hypoplasia of the inferior vena cava: an underappreciated cause of deep venous thromboses among young adults. Mil Med (2005) 0.77
Deep venous thrombosis caused by congenital malformation of the inferior vena cava and heterozygous factor V leiden presenting as venous claudication. Clin Appl Thromb Hemost (2008) 0.77
Validity of vaginal testing in detecting human papillomavirus (HPV) genotypes. J Clin Virol (2000) 1.43
Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs. Diabetes Metab (2012) 0.94
Seroprevalence of hepatitis C virus (HCV) infection among blood donors: a hospital-based study. Transfus Apher Sci (2001) 0.85
High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean. Clin Chem (2000) 0.77
An Arab selective gradient in the distribution of factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T. J Thromb Haemost (2005) 0.76
Molecular diagnosis of human papillomavirus: comparison between cervical and vaginal sampling. Infect Dis Obstet Gynecol (2001) 0.75
Detection of human papillomavirus (HPV) genotypes in cervico-vaginal scrapes of women with normal and abnormal cytology. Clin Microbiol Infect (2001) 0.75
The antiproliferative effect of glucocorticoids: is it related to induction of TGF-beta? Nephrol Dial Transplant (1998) 0.75
Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients. Transplant Proc (2003) 0.75